SCHEMBL7352004

SCHEMBL7352004

CN1CCN(C2CNc3c(N)cccc3C2)CC1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ADRA2C P18825 2/20 0.41
HTR3A P46098 2/20 0.34
HTR2A P28223 2/20 0.33
HTR2C P28335 2/20 0.33
HTR2B P41595 2/20 0.33
ALDH1A1 P00352 4/20 0.33
HRH4 Q9H3N8 2/20 0.33
DRD2 P14416 2/20 0.33
KDM4E B2RXH2 2/20 0.32
NPSR1 Q6W5P4 1/20 0.32
MAPK1 P28482 2/20 0.32
GAA P10253 2/20 0.32
GRIN2B Q13224 1/20 0.32
MAPT P10636 1/20 0.32
HTT P42858 1/20 0.32
RECQL P46063 1/20 0.32
PTK2B Q14289 1/20 0.32
DRD1 P21728 1/20 0.32
LMNA P02545 1/20 0.32
CYP3A4 P08684 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7372246 0.88 HTR1A (0.37) HTR2AHTR2CHTR2BGRIN2BHTR1A
SCHEMBL7351217 0.87 FYN (0.38) HTR2AHTR2CHTR2BGRIN2BHTR1A
SCHEMBL7797306 0.75 MEN1 (0.36) ADRA2CALDH1A1KDM4EGAAMAPT
SCHEMBL3593851 0.72 DRD2 (0.41) ADRA2CHTR2AHTR2CALDH1A1HRH4
SCHEMBL7351181 0.72 CYP19A1 (0.34)
SCHEMBL2845844 0.72 DRD2 (0.39) ALDH1A1DRD2KDM4EGAAMAPT
SCHEMBL6001937 0.70 GRIN2B (0.56) HTR2AHTR2CHTR2BALDH1A1DRD2
SCHEMBL7347949 0.70 DRD2 (0.37) HTR2AHTR2CHTR2BDRD2HTR1A
SCHEMBL22587954 0.68 MTNR1A (0.33) HTR2AHTR2CALDH1A1KDM4EGAA
SCHEMBL31285945 0.68 MTNR1A (0.33) HTR2AHTR2CALDH1A1KDM4EGAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5436240-A Schizophrenia, Parkinson's disease, depression or hypotensive agents using tricyclic amines THE UPJOHN COMPANY (US) 1995-07-25 US disclosed
EP-0480939-B1 HETEROCYCLIC AMINES HAVING CENTRAL NERVOUS SYSTEM ACTIVITY UPJOHN CO (US) 1995-01-25 EP disclosed
US-5273975-A Heterocyclic amines having central nervous system activity THE UPJOHN COMPANY (US) 1993-12-28 US disclosed
EP-0480939-A1 HETEROCYCLIC AMINES HAVING CENTRAL NERVOUS SYSTEM ACTIVITY. UPJOHN CO (US) 1992-04-22 EP disclosed
WO-1990015058-A1 HETEROCYCLIC AMINES HAVING CENTRAL NERVOUS SYSTEM ACTIVITY THE UPJOHN COMPANY (US) 1990-12-13 WO disclosed